_id
690db04bccc777a4e85d0b6d
Ticker
ARAY
Name
Accuray Incorporated
Exchange
NASDAQ
Address
1240 Deming Way, Madison, WI, United States, 53717-1954
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.accuray.com
Description
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Last Close
1.08
Volume
680990
Current Price
1.1
Change
1.8518518518518534
Last Updated
2025-11-28T12:20:36.226Z
Image
data:image/webp;base64,UklGRj4BAABXRUJQVlA4IDIBAACwCACdASpAAEAAPrVInUonJCKhsBYM+OAWiWcA1QRivOSUVCIIFhEevQ5UHXtj2zfGuJbyY5RX68d++1HJwXLedR/DEB6Sf1PqpVsI6gAA/vq35eRPeFSzJ7eM3S4lLrrN2LdgJwj2g9e3jgkCAjfKKJ8N13jFqPIUsxCMjFItTsdGpxRGqD7R4zl78EkNXPQCGpFaUesX5vU5Ti6PF+LWslK4/RN1kI2cnX7VEogN8DE1KG5wy5FoiDF1COECRP22/FwLE8AXXqbUOZtk51kxPq4ydh5UYPIHkOLGNyNrDGo8J4la7htXdeq3v3d/xre8Un+PnBbik2qmUb/u9uJuvCWvemQ7nygeMTHNlF78x3sKeOP96gf+RrgZlj4JBu9TXkIcGozkCqmYi9D7fd+QAAA=
Ipo Date
2007-02-08T00:00:00.000Z
Market Cap
117874776
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.989
Sentiment Sources
1
Rating
4.75
Target Price
3.875
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
93942000
Cost Of Revenue
67394000
Gross Profit
26548000
Operating Expenses
37861000
Operating Income
-11313000
Interest Expense
8052000
Pretax Income
-21207000
Net Income
-21678000
Eps
-0.18225076925663747
Dividends Per Share
-
Shares Outstanding
113341132
Income Tax Expense
471000
EBITDA
-10276000
Operating Margin
-12.042536884460626
Total Other Income Expense Net
-9894000
Cash
63916000
Short Term Investments
-
Receivables
61427000
Inventories
155503000
Total Current Assets
301260000
Property Plant Equipment
61112000
Total Assets
456816000
Payables
42400000
Short Term Debt
20316000
Long Term Debt
127316000
Total Liabilities
394949000
Equity
61867000
Depreciation
1676000
Change In Working Capital
21079000
Cash From Operations
12180000
Capital Expenditures
3824000
Cash From Investing
-3824000
Cash From Financing
-475000
Net Change In Cash
7794000
PE
-
PB
2.1148689931627525
ROE
-35.039681898265634
ROA
-4.745455500682989
FCF
8356000
Fcf Percent
0.08894850013838326
Piotroski FScore
2
Health Score
25
Deep Value Investing Score
5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
3
Momentum Investing Score
6
Net Net Investing Score
3.5
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
93942000
Quarters > 0 > income Statement > cost Of Revenue
67394000
Quarters > 0 > income Statement > gross Profit
26548000
Quarters > 0 > income Statement > operating Expenses
37861000
Quarters > 0 > income Statement > operating Income
-11313000
Quarters > 0 > income Statement > interest Expense
8052000
Quarters > 0 > income Statement > pretax Income
-21207000
Quarters > 0 > income Statement > net Income
-21678000
Quarters > 0 > income Statement > eps
-0.18225076925663747
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
118946000
Quarters > 0 > income Statement > income Tax Expense
471000
Quarters > 0 > income Statement > EBITDA
-10276000
Quarters > 0 > income Statement > operating Margin
-12.042536884460626
Quarters > 0 > income Statement > total Other Income Expense Net
-9894000
Quarters > 0 > balance Sheet > cash
63916000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
61427000
Quarters > 0 > balance Sheet > inventories
155503000
Quarters > 0 > balance Sheet > total Current Assets
301260000
Quarters > 0 > balance Sheet > property Plant Equipment
61112000
Quarters > 0 > balance Sheet > total Assets
456816000
Quarters > 0 > balance Sheet > payables
42400000
Quarters > 0 > balance Sheet > short Term Debt
20316000
Quarters > 0 > balance Sheet > long Term Debt
127316000
Quarters > 0 > balance Sheet > total Liabilities
394949000
Quarters > 0 > balance Sheet > equity
61867000
Quarters > 0 > cash Flow > net Income
-21678000
Quarters > 0 > cash Flow > depreciation
1676000
Quarters > 0 > cash Flow > change In Working Capital
21079000
Quarters > 0 > cash Flow > cash From Operations
12180000
Quarters > 0 > cash Flow > capital Expenditures
3824000
Quarters > 0 > cash Flow > cash From Investing
-3824000
Quarters > 0 > cash Flow > cash From Financing
-475000
Quarters > 0 > cash Flow > net Change In Cash
7794000
Quarters > 0 > ratios > PE
-0.18225076925663747
Quarters > 0 > ratios > PB
2.1148689931627525
Quarters > 0 > ratios > ROE
-35.039681898265634
Quarters > 0 > ratios > ROA
-4.745455500682989
Quarters > 0 > ratios > FCF
8356000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.08894850013838326
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
127543000
Quarters > 1 > income Statement > cost Of Revenue
88564000
Quarters > 1 > income Statement > gross Profit
38979000
Quarters > 1 > income Statement > operating Expenses
34745000
Quarters > 1 > income Statement > operating Income
4234000
Quarters > 1 > income Statement > interest Expense
4226000
Quarters > 1 > income Statement > pretax Income
2071000
Quarters > 1 > income Statement > net Income
1123000
Quarters > 1 > income Statement > eps
0.010313065358936918
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
108891000
Quarters > 1 > income Statement > income Tax Expense
948000
Quarters > 1 > income Statement > EBITDA
7895000
Quarters > 1 > income Statement > operating Margin
3.3196647405188835
Quarters > 1 > income Statement > total Other Income Expense Net
-2163000
Quarters > 1 > balance Sheet > cash
57416000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
97867000
Quarters > 1 > balance Sheet > inventories
141020000
Quarters > 1 > balance Sheet > total Current Assets
317465000
Quarters > 1 > balance Sheet > property Plant Equipment
61773000
Quarters > 1 > balance Sheet > total Assets
470239000
Quarters > 1 > balance Sheet > payables
34033000
Quarters > 1 > balance Sheet > short Term Debt
20109000
Quarters > 1 > balance Sheet > long Term Debt
123786000
Quarters > 1 > balance Sheet > total Liabilities
389070000
Quarters > 1 > balance Sheet > equity
81169000
Quarters > 1 > cash Flow > net Income
1123000
Quarters > 1 > cash Flow > depreciation
1598000
Quarters > 1 > cash Flow > change In Working Capital
-17965000
Quarters > 1 > cash Flow > cash From Operations
-9708000
Quarters > 1 > cash Flow > capital Expenditures
3402000
Quarters > 1 > cash Flow > cash From Investing
-3402000
Quarters > 1 > cash Flow > cash From Financing
-5845000
Quarters > 1 > cash Flow > net Change In Cash
-18110000
Quarters > 1 > ratios > PE
0.010313065358936918
Quarters > 1 > ratios > PB
1.475687762569454
Quarters > 1 > ratios > ROE
1.3835331222511058
Quarters > 1 > ratios > ROA
0.23881473038178455
Quarters > 1 > ratios > FCF
-13110000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.1027888633637283
Quarters > 1 > health Score
32
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
113243000
Quarters > 2 > income Statement > cost Of Revenue
81616000
Quarters > 2 > income Statement > gross Profit
31627000
Quarters > 2 > income Statement > operating Expenses
30580000
Quarters > 2 > income Statement > operating Income
1047000
Quarters > 2 > income Statement > interest Expense
14566000
Quarters > 2 > income Statement > pretax Income
-840000
Quarters > 2 > income Statement > net Income
-1297000
Quarters > 2 > income Statement > eps
-0.012613663992219791
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
102825000
Quarters > 2 > income Statement > income Tax Expense
457000
Quarters > 2 > income Statement > EBITDA
3625000
Quarters > 2 > income Statement > operating Margin
0.924560458483085
Quarters > 2 > income Statement > total Other Income Expense Net
-1887000
Quarters > 2 > balance Sheet > cash
77824000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
88982000
Quarters > 2 > balance Sheet > inventories
146445000
Quarters > 2 > balance Sheet > total Current Assets
333458000
Quarters > 2 > balance Sheet > property Plant Equipment
61104000
Quarters > 2 > balance Sheet > total Assets
484291000
Quarters > 2 > balance Sheet > payables
46319000
Quarters > 2 > balance Sheet > short Term Debt
14807000
Quarters > 2 > balance Sheet > long Term Debt
166209000
Quarters > 2 > balance Sheet > total Liabilities
434708000
Quarters > 2 > balance Sheet > equity
49583000
Quarters > 2 > cash Flow > net Income
-1297000
Quarters > 2 > cash Flow > depreciation
1575000
Quarters > 2 > cash Flow > change In Working Capital
12169000
Quarters > 2 > cash Flow > cash From Operations
18061000
Quarters > 2 > cash Flow > capital Expenditures
2431000
Quarters > 2 > cash Flow > cash From Investing
-2431000
Quarters > 2 > cash Flow > cash From Financing
-2000000
Quarters > 2 > cash Flow > net Change In Cash
14856000
Quarters > 2 > ratios > PE
-0.012613663992219791
Quarters > 2 > ratios > PB
2.281174999495795
Quarters > 2 > ratios > ROE
-2.615815904644737
Quarters > 2 > ratios > ROA
-0.2678141860988538
Quarters > 2 > ratios > FCF
15630000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.13802177618042616
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
116174000
Quarters > 3 > income Statement > cost Of Revenue
74282000
Quarters > 3 > income Statement > gross Profit
41892000
Quarters > 3 > income Statement > operating Expenses
37185000
Quarters > 3 > income Statement > operating Income
4707000
Quarters > 3 > income Statement > interest Expense
2883000
Quarters > 3 > income Statement > pretax Income
3232000
Quarters > 3 > income Statement > net Income
2537000
Quarters > 3 > income Statement > eps
0.024453954851271373
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
103746000
Quarters > 3 > income Statement > income Tax Expense
695000
Quarters > 3 > income Statement > EBITDA
7628000
Quarters > 3 > income Statement > operating Margin
4.051681099041094
Quarters > 3 > income Statement > total Other Income Expense Net
-1475000
Quarters > 3 > balance Sheet > cash
62584000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
94835000
Quarters > 3 > balance Sheet > inventories
148826000
Quarters > 3 > balance Sheet > total Current Assets
325891000
Quarters > 3 > balance Sheet > property Plant Equipment
58597000
Quarters > 3 > balance Sheet > total Assets
478382000
Quarters > 3 > balance Sheet > payables
53991000
Quarters > 3 > balance Sheet > short Term Debt
15078000
Quarters > 3 > balance Sheet > long Term Debt
167953000
Quarters > 3 > balance Sheet > total Liabilities
430491000
Quarters > 3 > balance Sheet > equity
47891000
Quarters > 3 > cash Flow > net Income
2537000
Quarters > 3 > cash Flow > depreciation
1513000
Quarters > 3 > cash Flow > change In Working Capital
12184000
Quarters > 3 > cash Flow > cash From Operations
1801000
Quarters > 3 > cash Flow > capital Expenditures
874000
Quarters > 3 > cash Flow > cash From Investing
-1570000
Quarters > 3 > cash Flow > cash From Financing
5766000
Quarters > 3 > cash Flow > net Change In Cash
4256000
Quarters > 3 > ratios > PE
0.024453954851271373
Quarters > 3 > ratios > PB
2.3829237226201165
Quarters > 3 > ratios > ROE
5.2974462842705305
Quarters > 3 > ratios > ROA
0.5303293184108098
Quarters > 3 > ratios > FCF
927000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.00797941019505225
Quarters > 3 > health Score
36
Valuation > metrics > PE
-0.18225076925663747
Valuation > metrics > PB
2.1148689931627525
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-35.039681898265634
Profitability > metrics > ROA
-7.195777733519219
Profitability > metrics > Net Margin
-0.23075940473909434
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
6.383839526726688
Risk > metrics > Interest Coverage
-1.4049925484351713
Risk > final Score
0
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.803558900440079
Liquidity > metrics > Quick Ratio
2.324079979590535
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
80
Prev Valuations > 2
100
Prev Profitabilities > 0
5
Prev Profitabilities > 1
0
Prev Profitabilities > 2
16
Prev Risks > 0
10
Prev Risks > 1
6
Prev Risks > 2
13
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T00:25:57.344Z
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAccuray Incorporated $ARAY Stock Holdings Increased by Armistice Capital LLC - Defense World
12/12/2025
Accuray Incorporated $ARAY Stock Holdings Increased by Armistice Capital LLC Defense World
Read more →S P Trends: Will ARAY stock split attract more investors - Fed Meeting & Free Community Supported Trade Ideas moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$3.875
Analyst Picks
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 55.39% of the total shares of Accuray Incorporated
1.
TCW Group Inc(10.5695%)
since
2025/06/30
2.
BlackRock Inc(8.0244%)
since
2025/06/30
3.
Vanguard Group Inc(4.7664%)
since
2025/06/30
4.
Neuberger Berman Group LLC(4.6606%)
since
2025/06/30
5.
Heartland Advisors Inc(4.4895%)
since
2025/06/30
6.
Armistice Capital, LLC(2.8719%)
since
2025/06/30
7.
Renaissance Technologies Corp(2.3114%)
since
2025/06/30
8.
Geode Capital Management, LLC(2.1493%)
since
2025/06/30
9.
State Street Corp(1.7696%)
since
2025/06/30
10.
Foundry Partners, LLC(1.5936%)
since
2025/03/31
11.
D. E. Shaw & Co LP(1.5916%)
since
2025/06/30
12.
UBS Group AG(1.5809%)
since
2025/06/30
13.
Tenor Capital Management Co Lp(1.3312%)
since
2025/06/30
14.
Harbert Fund Advisors Inc(1.2858%)
since
2025/06/30
15.
Acuitas Investments, LLC(1.2656%)
since
2025/06/30
16.
Dafna Capital Management LLC(1.0848%)
since
2025/06/30
17.
North Star Investment Management Corp(1.0586%)
since
2025/06/30
18.
Silverback Aset Management LLC(1.0349%)
since
2025/06/30
19.
Mackenzie Investments(0.9901%)
since
2025/06/30
20.
Kovack Advisors Inc(0.9562%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.